Dr. Klar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
160 E 34th St
4th Floor
New York, NY 10016Phone+1 212-731-6045
Summary
- Dr. Natalie Klar, based in New York, NY, is an oncologist specializing in breast cancer. She completed her fellowship in Hematology and Medical Oncology at NYU Grossman School of Medicine and her residency in Internal Medicine at UPMC Medical Education. Since 2019, she has worked as a Hematologist/Oncologist at NYU Langone Health. Her expertise includes breast cancer, hereditary breast and ovarian cancer syndrome, and triple-negative breast cancer. Dr. Klar has published several research papers in prominent journals like JAMA Oncology and the Journal of Clinical Oncology. She has been recognized with honors such as membership in the Alpha Omega Alpha Honor Medical Society and received the Matthew Harris Breast Cancer Research Fellowship from NYU Langone Health.
Education & Training
NYU Grossman School of MedicineFellowship, Hematology and Medical Oncology, 2019 - 2022
UPMC Medical EducationResidency, Internal Medicine, 2016 - 2019
Albany Medical CollegeClass of 2016
Certifications & Licensure
NY State Medical License 2019 - 2026
PA State Medical License 2016 - 2019
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Alpha Omega Alpha Honor Medical Society
- Matthew Harris Breast Cancer Research Fellow NYU Langone Health
Publications & Presentations
PubMed
- 3 citationsFertility Preservation and Assisted Reproduction in Patients With Breast Cancer Interrupting Adjuvant Endocrine Therapy to Attempt Pregnancy.Hatem A Azim Jr, Samuel M Niman, Ann H Partridge, Isabelle Demeestere, Monica Ruggeri
Journal of Clinical Oncology. 2024-08-10 - 4 citationsTumor-Infiltrating Lymphocytes in Patients With Stage I Triple-Negative Breast Cancer Untreated With Chemotherapy.Veerle C M Geurts, Sara Balduzzi, Tessa G Steenbruggen, Sabine C Linn, Sabine Siesling
JAMA Oncology. 2024-08-01 - 1 citationsRE: Adjuvant Aromatase Inhibitors or Tamoxifen following Chemotherapy for Perimenopausal Breast Cancer Patients.Natalie Klar, Sylvia Adams
Journal of the National Cancer Institute. 2021-08-16
Press Mentions
Breast Cancer Drug Could Trigger Dangerous High Blood SugarSeptember 26th, 2023- When Do You Need to Start Getting a Mammogram? New Research Says Starting at 40 Can Save LivesMarch 1st, 2024
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
